Skip to main content
ASHI 50th Annual Meeting Mobile App Main banner
Back
Abstract Session

Abstract III: Adaptive Immunity and Transplant Outcomes

Tuesday, October 22, 2024
4:45 PM – 6:15 PM US PDT
Location: Marquis Northeast

Presentations:

  • 4:45 PM – 5:00 PM US PDT
    Non-Permissive Hla-Dpb1 Mismatches are Associated with Increased 1-Year Mortality after Unrelated Donor Hematopoietic Cell Transplantation for Non-Malignant Disorders

    Speaker: Joselito Getz, MSc – Complexo Hospital de Clínicas - Federal University of Paraná

  • 5:00 PM – 5:15 PM US PDT
    Reconstitution of T Cells at Three Months after Stem Cell Transplant Influences the Discovery of Predictive Markers of Relapse

    Speaker: Amit Kalra, MBBS, MSc – University of Calgary

  • 5:15 PM – 5:30 PM US PDT
    Serological reactivity of HLA alleles is dependent on race/ethnicity

    Speaker: Nicole Valenzuela, PhD, F(ACHI) – UCLA

  • 5:30 PM – 5:45 PM US PDT
    Treatment with Bi-Specific Antibody Blinatumomab Effectively Reduces HLA Antibodies

    Speaker: Xiaohai (Sam) Zhang, PhD – Cedars Sinai Medical Center

  • 5:45 PM – 6:00 PM US PDT
    Ischemia-Reperfusion Injury Drives Increased Allosensitization to HLA-B, DQB1 and DPB1 and Leads to Poor Outcomes in Liver Transplant Recipients

    Speaker: Rebecca Sosa, PhD, F(ACHI) – UCLA Immunogenetics Center

  • 6:00 PM – 6:15 PM US PDT
    North Carolina Flow-XM Collaboration

    Speaker: Kristina Olack, MS, MLS – Atrium Health